The question is, is this still a ticket to early retirement, or are we looking at a beautifully designed, extremely expensive paperweight? Because let’s be honest, the stock market is full of things that look like a shortcut to wealth, but mostly just deliver stress and questionable life choices.
They make the stuff hospitals need. Not the glamorous, robot-assisted surgery bullshit—that’s for the Instagram doctors—but the surgical sealants, the beds, the IV drips. The mundane, vital infrastructure of a crumbling healthcare system. It’s not sexy, no. But old people break. A LOT. And the Baby Boomers? They’re not exactly slowing down the carnage. It’s a demographic inevitability, a slow-motion train wreck, and Baxter is selling the bandages. You can’t argue with that, not if you’re willing to look past the bloodstains.
Last night, Bloom reported a paltry $0.45 per share, scrubbed clean of unpleasant truths, on sales of $777.7 million. Enough to momentarily stir the pot, enough for the market to twitch. The stock, predictably, has offered a meager rise, about 1% as of this hour. A breadcrumb for the hopeful.
Look, I’m not saying it’s a turnaround. I’m saying it’s a momentary pause in the inevitable descent. They posted “encouraging” results. Encouraging? It was a 0.2% revenue increase. 0.2%! My toaster oven has more dramatic quarterly gains. But apparently, in this market, that’s enough to get people excited. It’s like lowering the bar until it’s lying flat on the ground and then celebrating the high jump.
Nvidia, in a move that can only be described as ‘doubling down on the digital future,’ has recently injected another $2 billion into CoreWeave. This isn’t just pocket change, you understand. It’s enough to buy a small country, or at least a very large server farm. The market, predictably, has reacted with a surge, bumping CoreWeave’s stock up a respectable 26% since the start of the year. But should you join the fray? That, as they say, is the question.
Three observations, presented not as bullish pronouncements, but as points requiring sober consideration, follow.
The act itself is unremarkable. Insiders, after all, are not statues, fixed and immutable. They possess lives, obligations, and, yes, even the occasional need to convert paper claims into something more…substantial. To ask why is often to chase shadows. This sale, representing roughly thirty percent of Mr. Westermann’s direct stake, is his first recorded disposition, a fact which, while noted, does not necessarily illuminate a grand design. His indirect holdings, thankfully, remain untouched – a small comfort in a world prone to upheaval.
They call it Artificial Intelligence. AI. The latest craze. Everyone’s chasing the phantom of automated profit. Palantir wasn’t born in this rush, though. They were digging in the dirt before the gold rush even started. They built their platform, AIP, to handle the messy, complicated stuff. Ontologies, they call the maps they create. Detailed layouts of a company’s data, zooming in on every little transaction, every whispered secret. It’s like an autopsy of a business, laid bare for anyone with the key.
So, TSMC. They make the processors. Ninety percent of the advanced chips. The AI stuff. Honestly, it’s not exactly rocket science, is it? It’s manufacturing. And they’re good at it. The stock’s up 262% in three years. Okay, fine. It’s good. But does anyone ever acknowledge the sheer inconvenience of needing processors? It’s a constant, nagging requirement of modern life. And now we’re supposed to be happy about it because this one company is doing well? Morningstar says they’ll be ahead for decades. Decades! Like we’re all supposed to plan our lives around TSMC’s projections? It’s preposterous.
Ford, after a period of distinctly uninspired performance, appears to have rediscovered its footing. The recent figures are… encouraging. One might even venture to say, promising. A steady ascent, however, is rarely dramatic. And the truly exquisite things in life, one finds, are seldom achieved without a touch of audacity.